China Tracker - Details for Dehaier Medical Systems (DHRM)

 Dehaier Medical Systems
 Basic Facts and History
Data Source: Annual Report for the period ended 2010-12-31
Reporting Type: U.S. Company (10-K Filings) 
Incorporation: British Virgin Islands 
Corporate Headquarters: China (Beijing) 
Going Public: IPO on 2010-04-22 
IPO Price: $8.00 (-78.88% since IPO)
IPO Lead Underwriter: Anderson & Strudwick 
Main Operating Subsidiary: Beijing Dehaier Medical Technology Co., founded 2003 
Investor Relations: Investor Relations Website 
Internal Controls: effective 
Internal Controls Audit: not performed 
Auditor Opinion:

The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. (Friedman LLP)

 
 Ownership
Main Shareholder: Ping Chen (CEO) 
Ownership: 24.55% 
 
 Auditor Trail (since January 1, 2009)
2010-01-01FriedmanAppointment
 
 Senior Management Trail (since January 1, 2009)
2003-01-01Zheng (Rita) LiuCFOAppointment
 
 Fiscal Year
Fiscal Year ends: December 31 
First Quarter 10-Q: due by 2018-05-15 
Second Quarter 10-Q: due by 2018-08-15 
Third Quarter 10-Q: due by 2017-11-15 
Annual Report 10-K: due by 2018-03-31 
DHRM
Healthcare & Drugs
SCORE
4
READ: Score Cards Explained
SAFETY/RISK SCORE
HIGH RISK
DETAILS: Safety/Risk Model for DHRM
Current Price:  $1.69
F10k Day (2010-04-22): -86.57%$12.58
2010 Close: -71.55%$5.94
2011 Close: 19.01%$1.42
High (2012-04-23): -57.22%$3.95
Low (2012-09-20): 14.96%$1.47
Exchange: NCM
Market Capitalization: 7.88 mill
Total Shares: 4.66 mill
Float: n/a
Avg Volume: 5.20 k
Short Interest: 9.30 k
Short Ratio: 0.25%1.8 d
Last Quarter: 2011-03-31
Revenue (MRQ): 2.95 mill
Net Income (MRQ): 0.20 mill
Op. Cash Flow (MRQ): -2.11 mill
all financial data provided without warranty